Patterns and risk factors associated with aromatase inhibitor-related arthralgia among breast cancer survivors.

@article{Mao2009PatternsAR,
  title={Patterns and risk factors associated with aromatase inhibitor-related arthralgia among breast cancer survivors.},
  author={Jun Mao and Carrie Tompkins Stricker and Deborah W. Bruner and Sharon X Xie and Marjorie A. Bowman and John Thruston Farrar and Brandon T Greene and Angela DeMichele},
  journal={Cancer},
  year={2009},
  volume={115 16},
  pages={3631-9}
}
BACKGROUND Arthralgia is common in postmenopausal breast cancer survivors (BCS) who are receiving aromatase inhibitors (AIs). The objective of this study was to evaluate the perceived onset, characteristics, and risk factors for AI-related arthralgia (AIA). METHODS In a cross-sectional survey of postmenopausal BCS who were receiving adjuvant AI therapy at a university-based oncology clinic, patient-reported attribution of AIs as a cause of joint pain was used as the primary outcome… CONTINUE READING
61 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 61 extracted citations

Similar Papers

Loading similar papers…